Pulished Date October, 2018
ID: 102
Share on
Share on

Latin America Nuclear Medicine Diagnostics Market By SPECT (Technetium-99m, Iodine, Thallium-201 And Others) And PET (Rubidium-82, Fluorine-18, And Others)), By Application (cardiology, Lymphoma, Thyroid, Neurology, Oncology) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 102
Pages: 135

Overview of the Market:
The Latin America nuclear medicine diagnostic market is estimated at $1.7 billion in 2018 and is expected to reach $3.09 billion by 2023, at a compound annual growth rate (CAGR) of 12.6%. Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness.

Until recent days, SPECT imaging was the most conventional modality for nuclear medicine applications. However, the trend is soon going to see a down side owing to shortage of molybdenum-99 isotope which in turn will lead to the deficiency of Technetium-99. Therefore, PET imaging products which include hybrid PET-CT scanners are estimated to account for a potentially hefty market share in the Nuclear Medicine Radiopharmaceuticals Diagnostics Market.

The emerging market will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness faster growth compared to SPECT imaging as it provides high resolution images. Lack of availability of technetium-99m is also forcing the industry to look for alternative diagnostic procedures that are more efficient and cheaper.

Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the major driving factors of the market. However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the key restraints for the growth of the nuclear medicine market.

The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application,the market is categorized into SPECT (lymphoma, cardiology,neurology,thyroid and others) and PET(cardiology,oncology, neurology and others).

Geographical Analysis: 
Furthermore, on the basis of geography, the Latin America Market is segmented into four regions namely, Argentina, Brazil and Mexico.

Key Players in this Market: 
Some of the key players influencing the Latin America nuclear medicine market are Cardinal Health, Inc., Bracco Imaging S.p.A,GE Healthcare,Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc.,Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Type                                                        

                                5.1.1 SPECT                                        

                                                5.1.1.1 Technetium-99m                              

                                                5.1.1.2 Thallium-201                       

                                                5.1.1.3 Gallium-67                           

                                                5.1.1.4 Iodine-23                             

                                                5.1.1.5 Others                   

                                5.1.2 PET                                             

                                                5.1.2.1 Fluorine-18                          

                                                5.1.2.2 Rubidium-82                       

                                                5.1.2.3 Others                   

                5.2 By Application                                                           

                                5.2.1 Cardiology                                               

                                5.2.2 Lymphoma                                              

                                5.2.3 Thyroid                                     

                                5.2.4 Neurology                                               

                                5.2.5 Oncology                                 

                                5.2.6 Others                                      

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 Brazil                                                             

                6.3 Argentina                                                    

                6.4 Mexico                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GE Healthcare                                                           

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Cardinal Health Inc.                                                 

                8.3 Bracco Imaging S.p.A                                                              

                8.4 Eczacibasi-Monrol Nuclear Products                                                

                8.5 Nordion, Inc.                                                              

                8.6 Bayer Healthcare                                                     

                8.7 Lantheus Medical Imaging, Inc.                                                          

                8.8 Advanced Accelerator Applications S.A.                                                         

                8.9 IBA Molecular Imaging                                                           

                8.10 Mallinckrodt plc.                                                    

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                          

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Nuclear Medicine Diagnostics Market By Region, From 2018-2023 (USD Billion)
  2. Latin America Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
  3. Latin America SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Billion)
  4. Latin America PET Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Billion)
  5. Latin America Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
  6. Latin America Cardiology Market By Region, From 2018-2023 (USD Billion)
  7. Latin America Lymphoma Market By Region, From 2018-2023 (USD Billion)
  8. Latin America Thyroid Market By Region, From 2018-2023 (USD Billion)
  9. Latin America Neurology Market By Region, From 2018-2023 (USD Billion)
  10. Latin America Oncology Market By Region, From 2018-2023 (USD Billion)
  11. Latin America Other Applications Market By Region, From 2018-2023 (USD Billion)
  12. Latin America SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  13. Latin America Technetium-99m Market By Region, From 2018-2023 ( USD Billion )
  14. Latin America Thallium-201 Market By Region, From 2018-2023 ( USD Billion )
  15. Latin America Gallium-67 Market By Region, From 2018-2023 ( USD Billion )
  16. Latin America Iodine-23 Market By Region, From 2018-2023 ( USD Billion )
  17. Latin America Other SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Billion )
  18. Latin America PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  19. Latin America Fluorine-18 Market By Region, From 2018-2023 ( USD Billion )
  20. Latin America Rubidium-82 Market By Region, From 2018-2023 ( USD Billion )
  21. Latin America Other PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Billion )
  22. Brazil Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
  23. Brazil Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
  24. Mexico Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
  25. Mexico Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
  26. Argentina Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
  27. Argentina Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
  28. Brazil SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  29. Mexico SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  30. Argentina SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  31. Brazil PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  32. Mexico PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
  33. Argentina PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients

Research Areas